1.Zhang Z, Yang C, Shen M.et al. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction. Stem Cell Res Ther. 2017;8(1):89.
2.Yue Y, Wang C, Benedict C.et al. Interleukin-10 Deficiency Alters Endothelial Progenitor Cell -Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment. Circ Res. 2020;126(3):315-329.
3.Huan Liu, Siying Liu, Xinyu Qiu.et al. Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells. Autophagy.2020; 29: 1-16.
4.Choe G, Kim SW, Park J.et al. Anti-oxidant activity reinforced reduced graphene oxide/alginate microgels: Mesenchymal stem cell encapsulation and regeneration of infarcted hearts. Biomaterials. 2019; 225: 119513.
5.Chen J, Zhan Y, Wang Y.et al. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats. Acta Biomater. 2018;80: 154-168.
6.Harrell CR, Fellabaum C, Jovicic N.et al. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 2019;8(5):467.).
7.Ye L, Fan Z, Yu B.et al. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell. 2012; 11: 50–61.
8.Golpanian S, Wolf A, Hatzistergos KE.et al. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016; 96: 1127–1168.
9.Barbash IM, Chouraqui P, Baron J.et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003; 108: 863–868.
10.Toma C, Wagner WR, Bowry S.et al. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res. 2009; 104: 398–402.
11.Tan X, Gong YZ, Wu P.et al. Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy. Int J Mol Sci. 2014; 15: 14348–14363.
12.Deng J, Yang C, Wang Y.et al. Inositol pyrophosphates mediated the apoptosis induced by hypoxic injury in bone marrow-derived mesenchymal stem cells by autophagy. Stem Cell Res Ther. 2019; 10:159.
13.Perakakis N, Triantafyllou GA, Fernández-Real JM.et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017; 13(6):324-337.
14.Bostrom P, Wu J, Jedrychowski MP.et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481: 463-468.
15.Fatouros IG. Is irisin the new player in exercise-induced adaptations or not? A 2017 update. Clin Chem Lab Med. 2018; 56: 525-548.
16.Yu Q, Kou W, Xu X.et al. FNDC5/Irisin inhibits pathological cardiac hypertrophy. Clin Sci (Lond). 2019; 133(5):611-627.
- Colaianni G, Cinti S, Colucci S. et al. Irisin and musculoskeletal health. Ann N Y Acad Sci. 2017;1402: 5-9.
18.Li RL, Wu SS, Wu Y. et al. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1pathway. Journal of Molecular and Cellular. 2018;121: 242-255.
19.Zhang X, Hu C, Kong CY.et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020; 27(2):540-555.
20.Ouyang H, Li Q, Zhong J.et al. (2020) Combination of melatonin and irisin ameliorates lipopolysaccharide‐induced cardiac dysfunction through suppressing the Mst1–JNK pathways. J Cell Physiol. doi: 10.1002/jcp.29561.
21.Dong Y, Zhang S, Tao J.et al. Fibronectin type III domain-containing protein 5 promotes proliferation and differentiation of goat adipose-derived stem cells. Res Vet Sci. 2019; 125: 351-359.
22.Zhang Z, Zhao CX, Liu B.et al. Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling. Stem Cell Res Ther. 2014; 5: 33.
23.Zhang Z, Li S, Cui M.et al. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways. Basic Res Cardiol. 2013; 108: 333.
24.Ling X, Wu W, Fan C.et al. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res. 2018; 37(1):240.
25.Liu B, Lee BW, Nakanishi K.et al. Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat Biomed Eng. 2018; 2(5):293-303.
26.Zhang Z, Liang D, Gao X.et al. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction. Basic Res Cardiol. 2014; 109(4):417.
27.Sun D, Huang J, Zhang Z.et al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One.2012; 7: e33491.
28.Zhang Z, Yang M, Wang Y, et al. Autophagy regulates the apoptosis of bone marrow-derived mesenchymal stem cells under hypoxic condition via AMP-activated protein kinase/mammalian target of rapamycin pathway. Cell Biol Int. 2016;40: 671-685.
29.Spinelli SV, Rodriguez JV, Quintana AB.et al. Engraftment and function of intrasplenically transplanted cold stored rat hepatocytes. Cell Transplant. 2002; 11: 161–168.
30.Yang XM, Wang YS, Zhang J.et al. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci. 2009; 50: 1873–1879.
31.Li Z, Wu JC, Sheikh AY.et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation. 2007; 116: 146–154.
32.Xiao C, Wang K, Xu Y.et al. Transplanted Mesenchymal Stem Cells Reduce Autophagic Flux in Infarcted Hearts via the Exosomal Transfer of miR-125b. Circ Res. 2018;123(5):564-578.
33.Young MF, Valaris S, Wrann CD. A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases. Prog Cardiovasc Dis. 2019; 62(2):172-178.
34.Lourenco MV, Frozza RL, de Freitas GB.et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nature Medicine. 2019; 25(1):165-175.
35.Han D, Huang W, Li X.et al. Melatonin facilitates adipose-derived mesenchymal stem cells to repair the murine infarcted heart via the SIRT1 signaling pathway. J. Pineal Res. 2016;60(2):178-192.
36.Cho HM, Lee KH, Shen YM. et al. Transplantation of human mesenchymal stem cells genome-edited with LEF1 improves cardio-protective effects in myocardial infarction. Mol Ther Nucleic Acids. 2020; 19:1186-1197.
37.Zhang Z, Zhu L, Feng P. et al. C1q/tumor necrosis factor-related protein- 3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction. Cell Death Dis. 2019; 10(7):530.